Belite Bio (BLTE) Tax Provisions (2023 - 2024)
Belite Bio (BLTE) recorded quarterly Tax Provisions of -$6.0 million in Q3 2024, down 199.9% quarter-over-quarter from $6.0 million in Q1 2024, and down 599500.0% on a YoY basis from N/an in Q4 2023.
Belite Bio (BLTE) Tax Provisions (2023 - 2024) Analysis & Trends
Belite Bio's Tax Provisions history runs 2 years deep, the most recent figure standing at -$6.0 million for Q3 2024.
- In Q3 2024, Tax Provisions fell 599500.0% year-over-year to -$6.0 million; the TTM figure through Dec 2024 stood at $6000.0 (down 99.93% YoY), while the FY2024 annual figure was $6000.0, down 33.33% from the prior year.
- Tax Provisions was -$6.0 million for Q3 2024 at Belite Bio, down from $6.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $6.0 million in Q1 2023 to a low of -$6.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 104.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -5.99 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 3.00 Mn |
| Mar 31, 2023 | 6.00 Mn |